<DOC>
	<DOCNO>NCT02410824</DOCNO>
	<brief_summary>Bilateral dispense clinical trial stenfilcon A etafilcon A astigmatism .</brief_summary>
	<brief_title>Bilateral Dispensing Clinical Trial Stenfilcon A Against Etafilcon A Astigmatism</brief_title>
	<detailed_description>CooperVision evaluate clinical performance FDA clear silicone-hydrogel lens material stenfilcon A ( test ) compare etafilcon A Astigmatism lens ( control ) wear daily wear basis one ( 1 ) week randomize , bilateral , cross-over , dispense study .</detailed_description>
	<mesh_term>Astigmatism</mesh_term>
	<criteria>Is least 17 year age Canada 18 year age USA full legal capacity volunteer ; Has read sign information consent letter ; Is willing able follow instruction maintain appointment schedule ; Is adapt soft contact lens wearer ; Requires spherical contact lens prescription 1.00 6.00 inclusive eye Has spectacle astigmatism : 0.50 1.50D ( Diopter ) cylinder ( Axis : 90±20 , 180±20 eye ) ; Willing wear contact lens eye least 8 hour per day , 7 day per week ; Has manifest refraction visual acuity ( VA ) equal good logMAR equivalent 20/25 eye ; To eligible lens dispense , subject must VA logMAR equivalent 20/30 good eye study lenses investigator must judge fit acceptable . Is participate concurrent clinical research study ; Has know active* ocular disease and/or infection ; Has systemic condition opinion investigator may affect study outcome variable ; Is use systemic topical medication opinion investigator may affect study outcome variable ; Has know sensitivity diagnostic pharmaceutical use study ; Is pregnant , lactate ( verbal confirmation screen visit ) ; Is aphakic ; Has undergone refractive error surgery</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>